Fact CheckerSign in

NCT04347655Recruiting

Assessing Systemic Circulation and LV Performance in Adults

A Novel Approach to the Assessment of the Systemic Circulation and Left Ventricular Performance in Adults

Source: ClinicalTrials.gov · Last updated 5 May 2026

Brief summary (registry, in English)

Background There are significant limitations in the current approaches to assessing 2 important areas of cardiovascular physiology - the systemic circulation and left ventricular (LV) performance. The investigators' have repurposed the concepts of "systemic vascular conductance" to assess systemic circulation, and the "head capacity principle" to assess LV performance. The investigators' now seek to test these concepts in human adults, with heart failure and without heart failure, using non-invasive methods. Hypothesis There will be a depressed head-capacity curve and reduced power among patients with heart failure which will indicate compromised left ventricular pump function. Methods The research study will involve a single outpatient visit per subject. The study will take place with the subject supine on a bed/table. The subjects will be instrumented with EKG electrodes and finger blood pressure cuffs. The continuous finger BP device performs a waveform analysis in real-time to determine the non-invasive stroke volume, cardiac output, and blood pressure. The patient will be supine for at least 5 minutes to collect baseline data before being handed a dynamometer device. The subject will then be asked to squeeze the dynamometer with maximum force for a minimum of 2 minutes while only engaging their forearm and remaining relaxed in the rest of their body. The subject will then release the dynamometer and remain supine, in recovery, for a minimum of 5 minutes. Following the handgrip test, the instrumentation will be removed and the patient's participation in the study will be complete. The study duration should be about 20 min.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
100 (estimated)
First submitted
12 Apr 2020
Start date
15 Sept 2021
Primary completion date
31 Dec 2028
Lead sponsor
University of Calgary
NCT number
NCT04347655

What you commit to

  • Study type: Interventional
  • Planned participants: 100
  • From 15 Sept 2021 to the primary completion date, 31 Dec 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • On intravenous inotrope or pressor medications to maintain their cardiac function

Other

  • Unable or unwilling to provide informed consent

Who the study is looking for

  • Age 18 years or older
  • Clinical heart failure (HFrEF or HFpEF) for heart failure patients and no clinical heart failure for the non-heart failure participants.

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University Of Calgary
Coordinator of this site? Confirm its status
CalgaryCanadaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.